About
Small Molecule, Antibody-Drug Conjugate
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalAntibodyNJ, NY, PA
Team (12)
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
1,376
By Phase
PHASE3: 3PHASE1: 1
By Status
RECRUITING: 2ACTIVE_NOT_RECRUITING: 2
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
Hover over trial bars to see details
Recent Trials
NCT07185997Lead Sponsor
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
PHASE3Recruiting
480 participants
Started: Dec 31, 2025 · Completed: Dec 31, 2030
NCT07010419Collaborator
A Study to Assess the Efficacy and Safety of Firmonertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB - IIIB NSCLC With Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations, Following Complete Surgical Resection With or Without Adjuvant Chemotherapy（FIRMOST）
PHASE3Recruiting
338 participants
Started: May 28, 2025 · Completed: Apr 30, 2032
NCT05607550Lead Sponsor
Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)
PHASE3Active, not recruiting
398 participants
Started: Jun 1, 2023 · Completed: Feb 15, 2028
NCT05364073Lead Sponsor
Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Mutations
PHASE1Active, not recruiting
160 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2025
Locations (1)
Headquarters
Newtown Square, PA, United States
Map
Loading map...